Intrust Bank NA Has $216,000 Stock Holdings in Avantor, Inc. (NYSE:AVTR)

Intrust Bank NA trimmed its holdings in Avantor, Inc. (NYSE:AVTR) by 10.4% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,473 shares of the company’s stock after selling 1,095 shares during the quarter. Intrust Bank NA’s holdings in Avantor were worth $216,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in AVTR. Fifth Third Bancorp lifted its position in shares of Avantor by 125.3% during the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock worth $28,000 after purchasing an additional 694 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its position in Avantor by 565.5% in the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock worth $30,000 after purchasing an additional 1,131 shares during the last quarter. GAMMA Investing LLC acquired a new position in Avantor during the 4th quarter worth $47,000. CKW Financial Group bought a new position in Avantor in the 4th quarter valued at $55,000. Finally, ORG Partners LLC bought a new stake in shares of Avantor during the fourth quarter worth $89,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on AVTR shares. UBS Group lifted their price objective on Avantor from $25.00 to $29.00 and gave the stock a “buy” rating in a research report on Thursday, February 15th. Robert W. Baird cut their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday. Barclays lifted their target price on shares of Avantor from $27.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft raised their price target on Avantor from $23.00 to $25.00 and gave the stock a “hold” rating in a research report on Thursday, April 18th. Finally, Evercore ISI raised their target price on Avantor from $26.00 to $28.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $26.71.

Avantor Price Performance

AVTR stock opened at $24.42 on Thursday. The stock has a 50-day moving average price of $25.09 and a two-hundred day moving average price of $22.69. Avantor, Inc. has a 1 year low of $16.63 and a 1 year high of $26.16. The stock has a market cap of $16.58 billion, a PE ratio of 62.60, a price-to-earnings-growth ratio of 1.47 and a beta of 1.37. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 0.94.

Avantor (NYSE:AVTR) last announced its earnings results on Friday, April 26th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $0.02. Avantor had a return on equity of 13.01% and a net margin of 3.79%. The business had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the firm earned $0.29 EPS. Avantor’s revenue for the quarter was down 5.6% compared to the same quarter last year. Equities analysts forecast that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

Insider Buying and Selling at Avantor

In other news, EVP James Bramwell sold 6,203 shares of the firm’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total value of $151,911.47. Following the completion of the transaction, the executive vice president now owns 101,143 shares in the company, valued at approximately $2,476,992.07. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.30% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.